UPMC-Magee Womens Hospital — Pittsburgh, Pennsylvania

UPMC-Magee Womens Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

UPMC-Magee Womens Hospital has participated in 163 clinical trials with 101 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Heron Therapeutics, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

• University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center
• UPMC Presbyterian Shadyside Hospital
• University of Pittsburgh Physicians
• University of Pittsburgh Division of Pulmonary
• ENT Department, Children's Hospital of Pittsburgh
• Site US10167 University of Pittsburgh Medical Center
• University of Pittsburgh Medical Center, CHF/Transplantation Cardiology
• UPMC Children's Hospital
• Duplicate_Allegheny General Hospital /ID# 215585
• University of Pittsburgh MC /ID# 65486
• UPMC Hillman Cancer Center, Magee-Womens Hospital
• University of Pittsburgh Medical Center Department of Dermatology

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC-Magee Womens Hospital?

UPMC-Magee Womens Hospital has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC-Magee Womens Hospital conducted?

UPMC-Magee Womens Hospital has 163 clinical trials on record, with 101 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is UPMC-Magee Womens Hospital accredited by Crixeo Clinical Trials?

UPMC-Magee Womens Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC-Magee Womens Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.